Tag Archive

Tag Archives for " lung cancer "

European Committee Approves Opdivo Advance

vaccine

Opdivo Advances in Europe In response to the decision made in the United States last March, manufacturer Bristol-Myers Squibb has announced a new dosing schedule for Opdivo (nivolumab), recommended by the Committee for Medicinal Products for Human Use of the European Medicines Agency. This new dosing schedule lets physicians choose to prescribe Opdivo as a […]

Continue reading